Radiation for cancer growth in prostate cancer that stopped responding to hormones
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether giving precise radiation to a few spots of cancer growth can help control prostate cancer that has stopped responding to hormone therapy. It is for people with up to 3 growing or new spots of cancer on a special scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of prostate cancer called adenocarcinoma.
- Your prostate cancer has stopped responding to hormone therapy (castration resistant) and your testosterone is very low.
- You have up to 3 areas of growth or new spots of cancer on a PSMA PET scan.
- You are currently on hormone therapy, possibly with other treatments like chemotherapy or ARTA (a type of hormone blocker).
- You are in generally good health (able to do daily activities, WHO score 0-2) and at least 18 years old.
- You have discussed your case with a team of cancer specialists and can give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving focused radiation to limited areas of cancer growth (up to 3 spots) can help control the disease in men with castration-resistant prostate cancer. You may be eligible if your cancer is growing slowly and you are already on hormone therapy.
This study tests whether adding a type of high-precision radiation (MDRT) to standard hormone therapy works better for men with prostate cancer that has spread to just a few places. It is for patients who are newly diagnosed and on long-term hormone therapy.
This trial tests whether giving focused radiation to a small number of growing prostate cancer spots can help control the disease while you continue your current systemic treatment. It may delay the need to switch treatments and is for people whose cancer has spread to only a few places.
This trial looks at whether a precise form of radiation (stereotactic body radiotherapy) can control a small number of prostate cancer spots seen on a special scan (PSMA PET/CT). It may help by treating limited metastases while avoiding unnecessary treatment elsewhere.
This trial studies the use of radiation to the prostate and to all visible spots where cancer has spread, in men who have up to 10 small areas of spread when first diagnosed. The goal is to see if this approach can help control the cancer.
This trial tests whether radiation therapy can help treat prostate cancer that has spread to only a few places in the body (oligometastatic). It aims to see if targeting both the prostate and the small number of metastases can improve outcomes.
Hear when a new Prostate Cancer (Adenocarcinoma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.